Applying the OMOP Common Data Model to Facilitate Benefit-Risk Assessments of Medicinal Products Using Real-World Data from Singapore and South Korea

Applying the OMOP Common Data Model to Facilitate Benefit-Risk Assessments of Medicinal Products Using Real-World Data from Singapore and South Korea

Objectives The aim of this study was to characterize the benefits of converting Electronic Medical Records (EMRs) to a common data model (CDM) and to assess the potential of CDM-converted data to rapidly generate insights for benefit-risk assessments in post-market regulatory evaluation and decision...

Full description

Bibliographic Details
Main Authors: Hui Xing Tan, Desmond Chun Hwee Teo, Dongyun Lee, Chungsoo Kim, Jing Wei Neo, Cynthia Sung, Haroun Chahed, Pei San Ang, Doreen Su Yin Tan, Rae Woong Park, Sreemanee Raaj Dorajoo
Format: Article
Language:English
Published: The Korean Society of Medical Informatics 2022-04-01
Series:Healthcare Informatics Research
Subjects:
pharmacovigilance
health policy
risk assessment
anticoagulants
data visualization
Online Access:http://e-hir.org/upload/pdf/hir-2022-28-2-112.pdf

Internet

http://e-hir.org/upload/pdf/hir-2022-28-2-112.pdf

Similar Items